Article
Pupils, visual fields show abnormalities, imaging studies demonstrate mass: What is the diagnosis?
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Optigo Bio receives People’s Choice Award for its proprietary drug anchoring
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Results of phase 2 clinical SAGA study of oral gildeuretinol for GA presented at ARVO 2025
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Beacon Therapeutics shares 6-month interim safety and efficacy results from Phase 2 DAWN study for XLRP
Assessment of AI-enabled screening for ROP in low-resource settings